CN107115219A - A kind of fibrous bud mother cell activating solution face pack prescription - Google Patents

A kind of fibrous bud mother cell activating solution face pack prescription Download PDF

Info

Publication number
CN107115219A
CN107115219A CN201710332402.5A CN201710332402A CN107115219A CN 107115219 A CN107115219 A CN 107115219A CN 201710332402 A CN201710332402 A CN 201710332402A CN 107115219 A CN107115219 A CN 107115219A
Authority
CN
China
Prior art keywords
activating solution
cell activating
face pack
mother cell
solution face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710332402.5A
Other languages
Chinese (zh)
Inventor
曹殿秀
李民
李一民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Sai'ou Cape Tule Biological Medicine Co Ltd
Original Assignee
Qingdao Sai'ou Cape Tule Biological Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Sai'ou Cape Tule Biological Medicine Co Ltd filed Critical Qingdao Sai'ou Cape Tule Biological Medicine Co Ltd
Priority to CN201710332402.5A priority Critical patent/CN107115219A/en
Publication of CN107115219A publication Critical patent/CN107115219A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of fibrous bud mother cell activating solution face pack prescription, including water, L tyrosine, L leucines, L threonines, L tyrosine, glycine, L glutamic acid, L phenylalanines, L proline, L valines, L glutamine, vitamin A, vitamin C, vitamin E, glycerine, propane diols, polyethylene glycol, hydroxyethyl cellulose, allantoin, Brij92, ribose, reduced glutathione and biotin.Fibrous bud mother cell activating solution face pack prescription of the present invention be used for skin care, can efficient activation cell, improve cell metabolism, effectively facilitate the hyperplasia of collagen, making the thickness of corium increase, recovery elasticity of skin, anti-aging.

Description

A kind of fibrous bud mother cell activating solution face pack prescription
Technical field
The present invention relates to a kind of activating solution, specifically a kind of fibrous bud mother cell activating solution face pack prescription.
Background technology
Cell activation liquid can not be absorbed using a variety of natural mineral matters as mainly material is adopted for human body among diet Mineral matter and various nutrient elements give the nutrient solution timely and effectively supplemented, are usually used in cosmetics, produce in the prior art The raw materials requirement amount of cell activation liquid is more, low production efficiency.
The content of the invention
It is an object of the invention to provide a kind of fibrous bud mother cell activating solution face pack prescription, to solve above-mentioned background technology The problem of middle proposition.
To achieve the above object, the present invention provides following technical scheme：
A kind of fibrous bud mother cell activating solution face pack prescription, including water, TYR, L-Leu, L-threonine, L- junket Propylhomoserin, glycine, Pidolidone, L-phenylalanine, L-PROLINE, Valine, Glu, vitamin A, vitamin C, Vitamin E, glycerine, propane diols, polyethylene glycol, hydroxyethyl cellulose, allantoin, Brij92, ribose, reduction paddy Guang Sweet peptide and biotin.
It is used as the preferred scheme of the present invention：Also include D-VB5 calcium, alternatively concentration is 1ng/ml to 10ng/ml.
It is used as the preferred scheme of the present invention：Also include i- inositols, alternatively concentration is 1ng/ml to 20ng/ml.
It is used as the preferred scheme of the present invention：Also include folic acid, alternatively concentration is 1ng/ml to 50ng/ml.
It is used as the preferred scheme of the present invention：Also include vitamin B12, alternatively concentration is 5ng/ml to 10ng/ml.
It is used as the preferred scheme of the present invention：Also include glucose, alternatively concentration is 5ng/ml to 150ng/ml.
Compared with prior art, the beneficial effects of the invention are as follows：Fibrous bud mother cell activating solution face pack prescription of the present invention is used In skin care, can efficient activation cell, improve cell metabolism, effectively facilitate the hyperplasia of collagen, make the thickness of corium Degree increase, recovers elasticity of skin, anti-aging.
Embodiment
The technical scheme in the embodiment of the present invention will be clearly and completely described below, it is clear that described implementation Example only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, this area is general The every other embodiment that logical technical staff is obtained under the premise of creative work is not made, belongs to what the present invention was protected Scope.
In the embodiment of the present invention, a kind of fibrous bud mother cell activating solution face pack prescription, including the bright ammonia of water, TYR, L- Acid, L-threonine, TYR, glycine, Pidolidone, L-phenylalanine, L-PROLINE, Valine, Glu, Vitamin A, vitamin C, vitamin E, glycerine, propane diols, polyethylene glycol, hydroxyethyl cellulose, allantoin, polyoxyethylene oleyl alcohol Ether, ribose, reduced glutathione and biotin.
Also include D-VB5 calcium, alternatively concentration is 1ng/ml to 10ng/ml.Also include i- inositols, alternatively concentration is 1ng/ml to 20ng/ml.Also include folic acid, alternatively concentration is 1ng/ml to 50ng/ml.Also include vitamin B12, alternatively Concentration is 5ng/ml to 10ng/ml.Also include glucose, alternatively concentration is 5ng/ml to 150ng/ml.

Claims (6)

1. a kind of fibrous bud mother cell activating solution face pack prescription, it is characterised in that including water, TYR, L-Leu, L- Soviet Unions Propylhomoserin, TYR, glycine, Pidolidone, L-phenylalanine, L-PROLINE, Valine, Glu, vitamin A, vitamin C, vitamin E, glycerine, propane diols, polyethylene glycol, hydroxyethyl cellulose, allantoin, Brij92, core Sugar, reduced glutathione and biotin.
2. a kind of fibrous bud mother cell activating solution face pack prescription according to claim 1, it is characterised in that also general including D- Sour calcium, alternatively concentration is 1ng/ml to 10ng/ml.
3. a kind of fibrous bud mother cell activating solution face pack prescription according to claim 1, it is characterised in that also including i- fleshes Alcohol, alternatively concentration is 1ng/ml to 20ng/ml.
4. a kind of fibrous bud mother cell activating solution face pack prescription according to claim 1, it is characterised in that also including leaf Acid, alternatively concentration is 1ng/ml to 50ng/ml.
5. a kind of fibrous bud mother cell activating solution face pack prescription according to claim 1, it is characterised in that also including dimension life Plain B12, alternatively concentration is 5ng/ml to 10ng/ml.
6. a kind of fibrous bud mother cell activating solution face pack prescription according to claim 1, it is characterised in that also including grape Sugar, alternatively concentration is 5ng/ml to 150ng/ml.
CN201710332402.5A 2017-05-12 2017-05-12 A kind of fibrous bud mother cell activating solution face pack prescription Pending CN107115219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710332402.5A CN107115219A (en) 2017-05-12 2017-05-12 A kind of fibrous bud mother cell activating solution face pack prescription

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710332402.5A CN107115219A (en) 2017-05-12 2017-05-12 A kind of fibrous bud mother cell activating solution face pack prescription

Publications (1)

Publication Number Publication Date
CN107115219A true CN107115219A (en) 2017-09-01

Family

ID=59726939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710332402.5A Pending CN107115219A (en) 2017-05-12 2017-05-12 A kind of fibrous bud mother cell activating solution face pack prescription

Country Status (1)

Country Link
CN (1) CN107115219A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109363965A (en) * 2018-09-29 2019-02-22 山东斯滕生物科技有限公司 Fibrous bud mother cell activating solution and facial mask

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1205737A (en) * 1995-12-21 1999-01-20 雀巢制品公司 Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof
CN103060264A (en) * 2012-12-20 2013-04-24 上海市第十人民医院 Stem cell culture medium and application thereof and stem cell cultivation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1205737A (en) * 1995-12-21 1999-01-20 雀巢制品公司 Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof
CN103060264A (en) * 2012-12-20 2013-04-24 上海市第十人民医院 Stem cell culture medium and application thereof and stem cell cultivation method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109363965A (en) * 2018-09-29 2019-02-22 山东斯滕生物科技有限公司 Fibrous bud mother cell activating solution and facial mask

Similar Documents

Publication Publication Date Title
CN102018727B (en) Preparation method of pearl hydrolysate
CN109517868B (en) Preparation method of fish-derived collagen peptide for delaying senescence
CN106011208A (en) Method for preparing small-molecular weight collagen active peptide through enzymolysis of yak bone and skin
MY161108A (en) Fermentation medias and processes thereof
CN103494723A (en) Stem cell skin care composition and manufacturing method and application thereof
CN105726457A (en) Oligopeptide mask essence
CN107692194A (en) It is a kind of can be with crease-resistant efficient collagen elastin laminin composite powder
Díaz et al. Applicability of enzymatic extracts obtained by solid state fermentation on grape pomace and orange peels mixtures in must clarification
CN107115219A (en) A kind of fibrous bud mother cell activating solution face pack prescription
HK1076633A1 (en) Production process of recombinant placental growth factor
AU4947500A (en) Process of expressing and isolating recombinant proteins and recombinant proteinproducts from plants, plant derived tissues or cultured plant cells
CN102334600A (en) Fermented feed and preparation method thereof
CN103520055B (en) Silkworm pupa polypeptide day cream and preparation method thereof
CN110840786A (en) Blue copper peptide essence and preparation method thereof
CN203885878U (en) Facial mask with alginic acid composite gelatinous fiber material layer
WO2002040686A3 (en) Expression system for recombinant proteins
CN104740677A (en) Medical repairing surgical dressing for skins and preparation method thereof
CN201281806Y (en) Health anion decompression wrist-watch
CN109223645A (en) A kind of better facial mask scavenging solution of humidity-preserving type
CN111759762A (en) Black eye removing composition, essence and preparation method thereof
CN112409469B (en) Extraction method of silk peptide
CN101073546A (en) Skin-whitening face mask
CN103484951B (en) The new application of bromelain and preparation thereof
CN101418257A (en) A kind of donkey hide gelatin grape health wine and production technique thereof
CN105168064B (en) A kind of concentrated type mineral matter maintenance Essence

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170901